Post-IPO Equity Medical Companies

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

Bright Minds Biosciences is a biotech company that engages in the development of serotonergic therapeutics to treat mental health disorders.

Harvard Apparatus Regenerative Technology is a biotechnology firm developing esophageal implants for patients battling threatening condition

Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

Intelligent Bio Solutions leverages the power of technology to develop transformative, accurate solutions that improve quality of life.

1933 Industries focuses on the cultivation and manufacturing of cannabis consumer branded goods in a range of product formats.

Tivic Health is a commercial health tech company that develops bioelectronic medicine to alleviate symptoms of inflammatory conditions.

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

1606 Corp is a smokable hemp brand of SinglePoint.

Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.

MetaOptics Technologies creates metalens and metasurface optics for AR, VR, IoT, and imaging devices using nanophotonics and AI.

Verrica Pharmaceuticals is an innovative clinical-stage medical dermatology company.

Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.

Autonomix Medical is a developer of a novel technology designed to bring clarity to minimally invasive renal denervation.

AEON Biopharma is a biopharmaceutical company that develops novel and proprietary treatment paradigms to improve patient outcomes.

Salarius Pharmaceuticals is an oncology-based biotechnology company developing new therapies to address gene dysregulation.

Veru is a biopharmaceutical company that specializes in developing novel medicines.

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

TempraMed provides last-mile control and management solutions to protect patients from temperature-sensitive medications.

Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.